Hims & Hers Health (NYSE:HIMS) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.03) by 1133.33 percent. This is a 317.65 percent decrease over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $753.214 million which beat the analyst consensus estimate of $699.889 million by 7.62 percent. This is a 38.25 percent increase over sales of $544.833 million the same period last year.